Charles River Launches New Retrogenix® Protein Library
Charles River Laboratories International, Inc. has introduced the Retrogenix® Non-Human Protein Library, a tool designed to assist biopharmaceutical companies...
AN2 Receives Grant for Boron-Based Therapies for Tuberculosis
AN2 Therapeutics, a biopharmaceutical company specializing in boron chemistry-based therapeutics, has secured continued research funding from the Bill &...
Innovating Biothreat Therapies: An Interview with Head of GigaGen
In this interview, Carter Keller, Head of GigaGen and SVP at Grifols, discusses the company’s groundbreaking work in developing...
Johnson & Johnson’s Innovative Approach to Enhancing Diversity in Clinical Trials
At DPHARM 2024, Johnson & Johnson (J&J) unveiled their groundbreaking strategies to improve diversity, equity, and inclusion (DE&I) in...
Cefiderocol Shows Strong Clinical Response in Global Study
Shionogi & Co., Ltd. has released new data from PROVE, a large-scale global study examining real-world evidence for Fetroja®/Fetcroja®...
Navigating Complexities in Obesity Clinical Trials: Insights from Skye Bioscience
In this interview, we met with Dr. Puneet Arora, Chief Medical Officer at Skye Bioscience, to explore the intricacies...
How To Leverage eClinical Technology to Enhance Sponsor-Site Collaboration
In this insightful discussion, we interview Kenny Kong, Vice President of Strategy for Veeva Site Connect. He delves into...
Transparency and Anonymization in Research: EMA Guidelines
As the clinical trial landscape evolves under the EU Clinical Trials Regulation (CTR), transparency and privacy have become central...
How to Navigate Rare Disease Clinical Trial Recruitment
In this discussion, we interview Sara Riordan, VP of Strategy at Genome Medical, on the complexities of recruiting for...
Navigating the Future of Clinical Trials: Insights from PicnicHealth Chief Medical Officer
In this interview, we speak with Dan Drozd, Chief Medical Officer at PicnicHealth, about the challenges and innovations in...